CN112451446A - Skin-tendering porcelain skin cream - Google Patents
Skin-tendering porcelain skin cream Download PDFInfo
- Publication number
- CN112451446A CN112451446A CN202011483781.6A CN202011483781A CN112451446A CN 112451446 A CN112451446 A CN 112451446A CN 202011483781 A CN202011483781 A CN 202011483781A CN 112451446 A CN112451446 A CN 112451446A
- Authority
- CN
- China
- Prior art keywords
- skin
- active substance
- porcelain
- tendering
- cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052573 porcelain Inorganic materials 0.000 title claims abstract description 18
- 239000002884 skin cream Substances 0.000 title claims abstract description 16
- 239000013543 active substance Substances 0.000 claims abstract description 45
- 230000002087 whitening effect Effects 0.000 claims abstract description 31
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 17
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- 239000011159 matrix material Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000006708 antioxidants Nutrition 0.000 claims description 13
- -1 acetyl chitosamine Chemical compound 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 244000178289 Verbascum thapsus Species 0.000 claims description 4
- 235000010599 Verbascum thapsus Nutrition 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 4
- 241000220317 Rosa Species 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- HWGKTCLOBSICTE-UHFFFAOYSA-N [3-decanoyloxy-2-[[3-decanoyloxy-2,2-bis(decanoyloxymethyl)propoxy]methyl]-2-(decanoyloxymethyl)propyl] decanoate Chemical compound CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)COCC(COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC HWGKTCLOBSICTE-UHFFFAOYSA-N 0.000 claims description 2
- JPDHZHZDXCSZAT-UHFFFAOYSA-N [3-octanoyloxy-2-[[3-octanoyloxy-2,2-bis(octanoyloxymethyl)propoxy]methyl]-2-(octanoyloxymethyl)propyl] octanoate Chemical compound CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC JPDHZHZDXCSZAT-UHFFFAOYSA-N 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 229910003472 fullerene Inorganic materials 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- 229940031674 laureth-7 Drugs 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 2
- 229960001679 octinoxate Drugs 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 2
- 229960000401 tranexamic acid Drugs 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 229940008099 dimethicone Drugs 0.000 claims 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 3
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000006267 biphenyl group Chemical group 0.000 claims 1
- 229940082500 cetostearyl alcohol Drugs 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 42
- 210000002615 epidermis Anatomy 0.000 abstract description 4
- 230000019612 pigmentation Effects 0.000 abstract description 4
- 230000000887 hydrating effect Effects 0.000 abstract description 2
- 239000002932 luster Substances 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a tender porcelain skin cream which comprises the following components in percentage by mass: 0.1-3% of whitening active substance, 0.3-2% of moisturizing active substance, 0.2-0.5% of antioxidant active substance and 94.5-99.4% of matrix material. Compared with the prior art, the invention has the advantages that: by adding the moisturizing active substances, moisturizing and hydrating are performed, the water content of the skin epidermis is maintained, the plumpness of the skin is improved, new visible light is generated, and the skin color is instantly brightened through luster reflection; the whitening active substance is added to effectively prevent and improve the pigmentation of the skin and realize deep whitening.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a skin-tendering porcelain skin cream.
Background
However, in the current society with increasingly worsened environment, the skin is easy to accelerate the internal aging of the skin and reduce the functions of skin cells due to factors such as external environment, such as ultraviolet radiation, dry and moist weather, irritant substances, allergens, environmental pollution and the like, so that the phenomena of skin wrinkles, skin aging, large skin pores, pigmentation and the like are generated. With the increase of age, the skin of a person becomes thin and loses elasticity, and subcutaneous adipose tissues supporting the skin of the person are lost under the action of gravity, so that the person loses youthful and beautiful appearance.
Smooth, fair and ruddy skin is sought by oriental women, most people use physical shielding products such as whitening and whitening powder for masking skin more than a decade ago, urban women seek more skin which is healthy from inside to outside today, and the skin state is moist, fair and young through the improvement of the whole skin state. Rejuvenation refers to rejuvenating the skin, primarily by whitening, and removing excess free radicals. Whitening skin care products are desired to be safe and effective. At present, the whitening agent with low concentration is difficult to have obvious effect when used at low concentration, and the whitening agent with high concentration is easy to cause skin irritation, so that the product has higher quality and more advanced technology.
Disclosure of Invention
The invention aims to provide a novel skin-care cosmetic which can keep moisture and moisturize by adding a moisture-keeping active substance, maintain the water content of the skin epidermal layer, improve the plumpness of the skin, generate new visible light and gloss reflection and realize instant brightening of the skin color; the whitening active substance is added, so that the pigmentation of the skin is effectively prevented and improved, and the deep whitening is realized.
The purpose of the invention is realized by the following technical scheme:
the skin-tendering porcelain skin cream comprises the following components in percentage by mass: 0.1-3% of whitening active substance, 0.3-2% of moisturizing active substance, 0.2-0.5% of antioxidant active substance and 94.5-99.4% of matrix material.
Further, the paint comprises the following components in percentage by mass: 2% of whitening active substance, 2% of moisturizing active substance, 0.35% of antioxidant active substance and 95.65% of matrix material.
Further, the paint comprises the following components in percentage by mass: 0.1% of whitening active substance, 0.3% of moisturizing active substance, 0.2% of antioxidant active substance and 99.4% of matrix material.
Further, the paint comprises the following components in percentage by mass: 3% of whitening active substance, 2% of moisturizing active substance, 0.5% of antioxidant active substance and 94.5% of matrix material.
Further, the whitening active substance is three or more of Glycyrrhiza Glabra (Glycyrrhiza Glabra) root extract, Verbascum Thapsus (Verbascum Thapsus) extract, Crystalide crystal highlight peptide, tranexamic acid and nicotinamide.
Further, the moisture-keeping active substance is a mixture of two or more of polymer sodium hyaluronate, acetyl chitosamine, rose leaf extract and wild soybean (Glycine SOJA) seed extract.
Further, the antioxidant active comprises fullerene, tocopherol and vitamin E.
Further, the matrix body comprises 10-15% of oil phase components, 81.4-83.5% of water phase components and 1-3% of additives.
Further, the oil phase component is one or a mixture of more of cetearyl alcohol, glyceryl stearate, PEG-100 stearate, C14-22 alcohol, C12-20 alkyl glucoside, dipentaerythritol hexacaprylate/hexacaprate, ethylhexyl methoxycinnamate, polydimethylsiloxane, diphenyl polydimethylsiloxane, cyclopentadimethylsiloxane, cyclohexasiloxane, caprylic/capric triglyceride; the water phase component is one or more of carbomer, glycerol, butanediol, EDTA-2 sodium and deionized water; the additive is one or more of triethanolamine, p-hydroxyacetophenone, 1, 2-hexanediol, polyacrylamide, C13-14 isoparaffin, and laureth-7.
Compared with the prior art, the invention has the advantages that:
the rose leaf extract utilizes plant extracts to protect the most important skin stem cells to delay skin aging, keep the skin young and endow the skin with unlimited vitality.
The Crystalide crystal highlight peptide comprises the following components: the skin care product comprises water, caprylic/capric triglyceride, cetyl palmitate, sorbitan stearate, polysorbate-80, hydrogenated lecithin and palmitoyl tetrapeptide, and can make the skin uniform, clear and bright by coordinating the mature differentiation of the epidermis to be glittering and translucent crystals.
The invention provides a skin-tendering porcelain skin cream which has multiple action mechanisms, visually brightens skin color, and obviously realizes the effects of tendering and beautifying skin and creating porcelain skin by matching with skin inner layer whitening. By adding the moisturizing active substances, moisturizing and hydrating are performed, the water content of the skin epidermis is maintained, the plumpness of the skin is improved, new visible light is generated, and the skin color is instantly brightened through luster reflection; the whitening active substance is added to effectively prevent and improve the pigmentation of the skin and realize deep whitening.
Detailed Description
Example 1
The skin-tendering porcelain skin cream comprises the following components in percentage by mass: 2% of whitening active substance, 2% of moisturizing active substance, 0.35% of antioxidant active substance and 95.65% of matrix material.
Example 2
The skin-tendering porcelain skin cream comprises the following components in percentage by mass: 0.1% of whitening active substance, 0.3% of moisturizing active substance, 0.2% of antioxidant active substance and 99.4% of matrix material.
Example 3
The skin-tendering porcelain skin cream comprises the following components in percentage by mass: 3% of whitening active substance, 2% of moisturizing active substance, 0.5% of antioxidant active substance and 94.5% of matrix material.
Comparative example 1
The difference from example 1 is that no moisturizing active was added.
Comparative example 2
The difference from example 1 is that no whitening active was added.
50 volunteers (20 men and 30 women) were selected from the skin-care cream prepared in examples 1 to 3 and comparative examples 1 to 2 and used for 2 weeks, 1 time each in the morning and evening, and the cream was used after the skin of the face was cleaned. The effect of the use was evaluated and shown in Table 1.
Table 1: enhancing skin color score
As shown in the evaluation of the subjects in Table 1, the subjects fed back the instant whitening effect, and the skin color became white after long-term use, and no allergy was observed.
Trial tests were conducted on the products prepared in examples 1-3 and comparative examples 1-2 to examine the effects.
Test objects: each experimental group selects 60 testers (male 20 and female 40) with dry facial skin and spots, the testers are tried for 1 time every day and used for 4 weeks continuously, and a testing instrument: skin melanin and heme tester (Mexameter MX 18).
The method comprises the following steps: after the test of the testee, after the testee cleans the face on the day and sits still for 30min in an environment with the room temperature of 23-25 ℃ and the relative humidity of 50-60%, the testee pays attention to the relaxation of the facial muscle group and slightly closes the eyes. The melanin precipitation of facial skin was measured by a skin melanin and heme tester (Mexameter MX18), and the measurement was repeated 3 times by a probe in the same area to be measured, and the average value was obtained. The relative temperature of the test environment is kept during measurement, the influence of light and sound interference is avoided, force is uniformly applied when the probe is used, and the applied pressure is constant. The subjects used for 1 week, 2 weeks, 3 weeks, 4 weeks before measuring the melanin status of the test area again. The measurement is finished, the data is saved, and the data is collated and analyzed as shown in table 2.
As can be seen from the results of the change in the skin melanin number of the tested part of the test person in table 2, the skin whitening and porcelain skin cream provided by the embodiment of the invention has whitening effect on the skin of most test persons, effectively improves skin pigmentation, reduces the skin dryness, and presents a tender and fair skin, and no irritation and allergy phenomenon of the product to the test person is found.
Claims (9)
1. The skin-tendering porcelain skin cream is characterized by comprising the following components in percentage by mass: 0.1-3% of whitening active substance, 0.3-2% of moisturizing active substance, 0.2-0.5% of antioxidant active substance and 94.5-99.4% of matrix material.
2. The skin-tendering porcelain skin cream according to claim 1, which is characterized by comprising the following components in percentage by mass: 2% of whitening active substance, 2% of moisturizing active substance, 0.35% of antioxidant active substance and 95.65% of matrix material.
3. The skin-tendering porcelain skin cream according to claim 1, which is characterized by comprising the following components in percentage by mass: 0.1% of whitening active substance, 0.3% of moisturizing active substance, 0.2% of antioxidant active substance and 99.4% of matrix material.
4. The skin-tendering porcelain skin cream according to claim 1, which is characterized by comprising the following components in percentage by mass: 3% of whitening active substance, 2% of moisturizing active substance, 0.5% of antioxidant active substance and 94.5% of matrix material.
5. The cream of any one of claims 1 to 4, wherein the whitening active is a mixture of three or more of Glycyrrhiza Glabra (Glycyrrhiza Glabra) root extract, Verbascum Thapsus (Verbascum Thapsus) extract, Crystalide crystal highlight peptide, tranexamic acid, and nicotinamide.
6. The skin-care porcelain skin cream as claimed in any one of claims 1 to 4, wherein the moisture-keeping active substance is a mixture of two or more of sodium hyaluronate, acetyl chitosamine, rose leaf extract, and wild soybean (Glycine SOJA) seed extract.
7. The skin tendering and porcelain skin cream as claimed in any one of claims 1 to 4, wherein the antioxidant active comprises fullerene, tocopherol vitamin E.
8. The skin-tendering porcelain muscle cream as claimed in any one of claims 1 to 4, wherein the matrix material comprises 10 to 15% of oil phase component, 81.4 to 83.5% of water phase component and 1 to 3% of additive.
9. The cream of claim 8, wherein the oily phase component is one or more of cetostearyl alcohol, glyceryl stearate, PEG-100 stearate, C14-22 alcohol, C12-20 alkyl glucoside, dipentaerythritol hexacaprylate/hexacaprate, ethylhexyl methoxycinnamate, dimethicone, diphenyl dimethicone, cyclopentadecyl dimethicone, cyclohexasiloxane, caprylic/capric triglyceride; the water phase component is one or more of carbomer, glycerol, butanediol, EDTA-2 sodium and deionized water; the additive is one or more of triethanolamine, p-hydroxyacetophenone, 1, 2-hexanediol, polyacrylamide, C13-14 isoparaffin, and laureth-7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011483781.6A CN112451446A (en) | 2020-12-16 | 2020-12-16 | Skin-tendering porcelain skin cream |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011483781.6A CN112451446A (en) | 2020-12-16 | 2020-12-16 | Skin-tendering porcelain skin cream |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112451446A true CN112451446A (en) | 2021-03-09 |
Family
ID=74804375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011483781.6A Pending CN112451446A (en) | 2020-12-16 | 2020-12-16 | Skin-tendering porcelain skin cream |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112451446A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114404359A (en) * | 2022-01-28 | 2022-04-29 | 湖南伟方生命科技有限公司 | Gynecological whitening and moistening nursing gel and preparation method thereof |
-
2020
- 2020-12-16 CN CN202011483781.6A patent/CN112451446A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114404359A (en) * | 2022-01-28 | 2022-04-29 | 湖南伟方生命科技有限公司 | Gynecological whitening and moistening nursing gel and preparation method thereof |
| CN114404359B (en) * | 2022-01-28 | 2024-04-02 | 湖南伟方生命科技有限公司 | Gynecological whitening and moisturizing nursing gel and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1028705B1 (en) | Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells | |
| KR101438367B1 (en) | Composition of skin external application containing ginseng fruit extracts | |
| CN111686029A (en) | Anti-aging wrinkle-removing composition | |
| CN110327261A (en) | A kind of compact skin skin care compositions and preparation method thereof | |
| CN110448511A (en) | The skin conditioning agent of a kind of anticreep adornment and anti-blue light, plain face frost and preparation method thereof | |
| WO2010067212A2 (en) | A complex of active vegetal stem cells and a cosmetic composition | |
| CN111000748A (en) | Polypeptide repairing cream and preparation method thereof | |
| ITMI20130218A1 (en) | COMPOSITION FOR COSMETIC USE TO PRODUCE A HAIR PIGMENTATION EFFECT | |
| Gaspar et al. | Evaluation of dermatological effects of cosmetic formulations containing Saccharomyces cerevisiae extract and vitamins | |
| CN109363976A (en) | It is a kind of to lift compact facial mask and preparation method thereof | |
| CN108113920B (en) | Slow-release whitening composite moisturizing cream matrix and preparation method and application thereof | |
| KR101480693B1 (en) | Anti-aging cosmetic composition for skin | |
| CN109303727A (en) | A kind of compound anti-apolexis composition and its application containing plant extracts | |
| CN111358734A (en) | A warehouse-separated anti-aging cosmetic composition | |
| KR101915655B1 (en) | Cosmetic composition containing Croton Lechleri resin extract | |
| CN113576975A (en) | Easily-absorbed anti-aging composition and preparation method and application thereof | |
| CA2326528C (en) | Cholesterol sulfate compositions for artificial skin tanning | |
| CN115040464A (en) | Essence composition with wrinkle-removing and anti-aging effects and preparation method thereof | |
| CN112451446A (en) | Skin-tendering porcelain skin cream | |
| KR101239393B1 (en) | Cosmetic composition for anti-wrinkle containing natural extract | |
| CN111557872A (en) | Skin care product of multi-oligopeptide composition | |
| CN111012713A (en) | Whitening composition and preparation method and application thereof | |
| CN112386547A (en) | Skin health care application of pineapple extract | |
| CN115869230A (en) | Anti-wrinkle cosmetic and preparation method thereof | |
| WO2014167557A1 (en) | Cosmetic topical skin treatment formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210309 |